Business Development Legal Policy Practice Regulatory

News

Biosimilar Adoption Faces Serious Challenges Due to CMS Coverage Gap

The potential cost savings offered by biosimilars may never be realized in the United States if reimbursement incentives are not implemented to ensure their adoption and long-term use, according to industry expert Molly Burich.

Legal Battles Over the Biosimilars Patent Dance Continue in Amgen v Hospira

The ongoing district court litigation of Amgen v Hospira—a case regarding Hospira’s proposed biosimilar to epoetin alfa (Epogen), a biological agent used to treat anemia—progressed on May 26, 2017, when counsel for Amgen filed a motion for a preliminary injunction.

Formulary Management an Important Consideration for Biosimilar Stakeholders

Molly Billstein Leber, PharmD, BCPS, FASHP

Soaring Drug Prices Lead to Pharma Industry Finger-Pointing

Soaring Drug Prices Lead to Pharma Industry Finger-Pointing

Comments on the FDA's Biosimilar Interchangeability Draft Guidance Highlight a Growing Need for Clarity

Comments on the FDA's Biosimilar Interchangeability Draft Guidance Highlight a Growing Need for Clarity

FDA Commissioner Gottlieb Will Work in a Variety of Ways to Contain Drug Prices

FDA Commissioner Gottlieb Will Work in a Variety of Ways to Contain Drug Prices

UK Authority: Merck Used Illegal Discounts to Defend Against Biosimilar Competition to Remicade

Christina Mattina

Pfizer's Epogen Biosimilar Called "Highly Similar" to Reference Drug

New Bill in Nevada Spotlights Ambiguity in Insulin Pricing

New Bill in Nevada Spotlights Ambiguity in Insulin Pricing

Certolizumab Responsible for Higher Costs, Pneumonia Rates Than Adalimumab, Etanercept

Christina Mattina

Celltrion to Play With 4 Brand Names in the EU With Rituximab Biosimilar

EMA Recommends Approval of Sanofi's Insulin Lispro Biosimilar

Janssen Moves to Block Marketing of Renflexis in Suit Against Samsung Bioepis

Janssen Moves to Block Marketing of Renflexis in Suit Against Samsung Bioepis

Surabhi Dangi-Garimella, PhD

Biopharma Companies Seek Greater Clarification About FDA's Interchangeability Guidance

US Congressional Delegation Expresses Concern Over Biosimilar Reimbursement Policy

US Congressional Delegation Expresses Concern Over Biosimilar Reimbursement Policy

AbbVie Loses Humira Patent Challenge to Coherus

Christina Mattina

Yet Another Pegfilgrastim Biosimilar Candidate Announces Positive Clinical Study Data

New FDA Commissioner Will Prioritize Opioid Crisis, Drug Pricing

Framework Proposed to Incorporate Biosimilars Education Into Pharmacist Curriculum

Framework Proposed to Incorporate Biosimilars Education Into Pharmacist Curriculum

Christina Mattina

Switch from Remicade to Inflectra Did Not Affect Efficacy, Per Danish Study

Switch from Remicade to Inflectra Did Not Affect Efficacy, Per Danish Study

Biosimilar Competition Has Led to Consistent Price Reduction in Europe

Biosimilar Competition Has Led to Consistent Price Reduction in Europe

European Guide for Prescribers Assures Safety and Effectiveness of Biosimilars

European Guide for Prescribers Assures Safety and Effectiveness of Biosimilars

Christina Mattina

Strong Early Launch for New Eczema Drug Dupilumab, Despite Price

Strong Early Launch for New Eczema Drug Dupilumab, Despite Price

Three Studies at DDW 2017 Suggest Infliximab Biosimilar Getting Closer to Interchangeability

Senate Confirms Scott Gottlieb as FDA Commissioner

Surabhi Dangi-Garimella, PhD

Drug Pricing Not Discussed at White House Meeting of Biotech Execs and NIH

Drug Pricing Not Discussed at White House Meeting of Biotech Execs and NIH

WHO to Start Pilot Prequalification of Biosimilars for 2 Cancer Treatments

WHO to Start Pilot Prequalification of Biosimilars for 2 Cancer Treatments

ICER Issues Draft Evidence Report on Biologics for Osteoporosis

ICER Issues Draft Evidence Report on Biologics for Osteoporosis

Celltrion Plans Filing for Biosimilars to Rituximab, Trastuzumab

Biosimilars at the Gates: What's Ahead?

...

149 150 151 152 153 154 155 156 157

...

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.